ScreenerHero

TGIF 1933 Industries Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · 1933industries.com
0.0100CAD0.00%Mkt Cap: 3.79M $P/E: —

1933 Industries Inc., together with its subsidiaries, engages in the cultivation, extraction, and production of cannabis products in the United States. It operates through AMA and Infused MFG segments. The company offers…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap3.79M USD
Enterprise Value14.74M USD
Revenue (TTM)12.02M USD
Gross Profit3.76M USD
Net Income (TTM)-158.06K USD
Revenue/Share0.03 CAD
Last Price0.0100 CAD
Fiscal Year EndJul 2025
MR QuarterApr 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA65442F1053
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-55.25
EV/Revenue1.23
P/S0.32
P/B-1.67
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.005033% of range0.0200
52W High0.0200 CAD
52W Low0.0050 CAD
Profitability
Gross Margin29.60%
Oper. Margin8.89%
EBITDA Margin-2.22%
Profit Margin-1.24%
ROE4.72%
ROA-1.29%
Growth
Revenue Growth-9.30%
Earnings Growth-6.70%
Cash Flow & Leverage
Operating CF1.34M USD
CapEx (TTM)123.24K USD
FCF Margin-8.73%
FCF Yield-27.67%
Net Debt10.95M USD
Net Debt/EBITDA-41.03
Balance Sheet
Debt/Equity-3.83
Current Ratio1.11
Quick Ratio0.44
Book Value/Sh-0.0060 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateFeb 18, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.520.76M
Float482.19M
Insiders7.84%
Institutions0.01%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short16.28K
Short (prev mo.)47
Technical
SMA 500.0089 (+12.4%)
SMA 2000.0091 (+9.6%)
Beta1.50
S&P 52W Chg16.45%
Avg Vol (30d)128.36K
Avg Vol (10d)132.97K
Technical Indicators
RSI (14)52.6
MACD0.0011
MACD Signal0.0010
MACD Hist.+0.0002
BB Upper0.0142 CAD
BB Middle0.0090 CAD
BB Lower0.0038 CAD
BB Width116.26%
ATR (14)0.0032 CAD
Vol Ratio (20d)1.82x